Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Cancers
|
April 13, 2023
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas after Image-Guided Cryoablation or Radio-Frequency Ablation
Aqua Asif, Vinson Wai-Shun Chan, Filzah Hanis Osman, et al.
European Radiology
|
February 5, 2022
The changing trends of image-guided biopsy of small renal masses before intervention-an analysis of European multinational prospective EuRECA registry
Vinson Wai-Shun Chan, Francis Xavier Keeley, Brunolf Lagerveld, et al.
Digestive Surgery
|
April 16, 2025
Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q)
Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, et al.
Radiology
|
September 3, 2024
The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors
Mishal Mendiratta-Lala, Philipp Wiggermann, Maciej Pech, et al.
Annals of Surgery
|
April 9, 2025
The #HOPE4LIVER single-arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors: 1-year Update of Clinical Outcomes
Timothy J Ziemlewicz, Jeffrey J Critchfield, Mishal Mendiratta-Lala, et al.
The Lancet. Oncology
|
February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
Janet E Brown, Kara-Louise Royle, Walter Gregory, et al.
Health Technology Assessment (Winchester, England)
|
September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
Fiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Cancers
|
April 13, 2023
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas after Image-Guided Cryoablation or Radio-Frequency Ablation
Aqua Asif, Vinson Wai-Shun Chan, Filzah Hanis Osman, et al.
European Radiology
|
February 5, 2022
The changing trends of image-guided biopsy of small renal masses before intervention-an analysis of European multinational prospective EuRECA registry
Vinson Wai-Shun Chan, Francis Xavier Keeley, Brunolf Lagerveld, et al.
Digestive Surgery
|
April 16, 2025
Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q)
Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, et al.
Radiology
|
September 3, 2024
The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors
Mishal Mendiratta-Lala, Philipp Wiggermann, Maciej Pech, et al.
Annals of Surgery
|
April 9, 2025
The #HOPE4LIVER single-arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors: 1-year Update of Clinical Outcomes
Timothy J Ziemlewicz, Jeffrey J Critchfield, Mishal Mendiratta-Lala, et al.
The Lancet. Oncology
|
February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
Janet E Brown, Kara-Louise Royle, Walter Gregory, et al.
Health Technology Assessment (Winchester, England)
|
September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
Fiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
Page
of 4